ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 698278 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 698278; 2) Community: the network communities that were significantly associated with the response to NSC 698278; 3) Molecule: the relationships between components within communities and NSC 698278; 4) MDR: the compounds that were significantly associated with the NSC 698278.

NSC Compound Enrichment Correlation
NSC 653846 Benzoic acid, 2-hydroxy-, 2-[(3,4-dimethoxyphenyl)(cyano) methyl]hyrazide 0.0382675857669588 -0.1424829
NSC 658874 Null 0.0382675857669588 -0.013575871
NSC 659948 7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0382675857669588 0.027903832
NSC 665524 Null 0.0382675857669588 0.055157059
NSC 677244 Null 0.0382675857669588 0.011475329
NSC 680781 2(3H)-Furanone, dihydro-3-[1-[(4-chlorophenyl)amino] ethylidene]- 0.0382675857669588 -0.0072757042
NSC 681635 Camptothecin Derivative 0.0382675857669588 -0.019867914
NSC 682835 Propanimidoyl chloride, N-[[[(5-fluoro-2-methylphenyl) amino]carbonyl]oxy]- 0.0382675857669588 0.71827138
NSC 682840 Butanimidoyl chloride, N-[[[[4-(trifluoromethoxy)phenyl] amino]carbonyl]oxy]- 0.0382675857669588 0.64233356
NSC 694002 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0382675857669588 0.67124491
Total:61  Current:46    [First] [Prev] [Next] [Last]